FDA announces single pivotal trial approval standard
Cytel discusses policy change, trial design focus, and remaining questions.
See the latest news and media coverage for Cytel. We track all announcements, press releases, and industry mentions in real time, all in one place.
Data science CRO for clinical trial analytics and software
cytel.comLast updated
In short: Cytel expanded its clinical research capabilities through AI-focused guidelines, strategic biostatistics consulting, and optimized trial designs.
Cytel discusses policy change, trial design focus, and remaining questions.
Cytel’s East Horizon™ platform integrates trial design, simulation, and AI tools for scenario testing, risk mitigation, and faster decisions. Learn more: [link]
Credits dedicated RWE team. Offers solutions integrating data collection, analytics, and expertise for regulatory submissions, clinical strategy, and market access.
Mike Fossler outlines the FDA's long-term strategy to reduce or eliminate animal toxicology studies and addresses concerns about animal-to-human predictivity.
Cambridge, MA and St. Paul, MN, May 09, 2025 (GLOBE NEWSWIRE) -- Cytel, a global leader in evidence generation and data-driven decision-making, today announced a...
Cytel Inc. Release Summary. Cytel Inc. has acquired stève consultants, specialists in market access, real-world (RWE), and health economics and...
GSK signs deal for Cytel's Solara clinical trial strategy platform. The Solara platform is developed for simulation-guided clinical study design...
Nordic and Astorg to buy New Mountain Capital's Cytel in $1bn deal. Benefiting from existing trends that are accelerating through the global...
Track Cytel and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Cytel and other trending companies.